A Comparison Between Pupillometry, Heart Rate Variability and Metaiodobenzylguanidine Scintigraphy for the Diagnosis of Early Diabetic Autonomic Neuropathy in Type 1 Diabetes

NCT01822431 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2013-04-02

No results posted yet for this study

Summary

This study will examine if one of the following methods: pupillometry, spectral analysis of heart rate variability and metaiodobenzylguanidine scintigraphy, is more capable to detect early diabetic autonomic neuropathy in patients with type 1 diabetes mellitus

Conditions

  • Autonomic Neuropathy

Interventions

RADIATION

metaiodobenzylguanidine scintigraphy

Sponsors & Collaborators

  • AHEPA University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2013-06-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01822431 on ClinicalTrials.gov